Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Energizer: PGC-1 alpha keeps the heart going.

Motoaki Sano1, Michael D Schneider

  • 1Department of Medicine, Center for Cardiovascular Development, Baylor College of Medicine, Houston, Texas 77030, USA.

Cell Metabolism
|August 2, 2005
PubMed
Summary

This study investigated the role of PGC-1alpha in heart metabolism using genetically modified mice. The researchers found that PGC-1alpha is essential for maintaining mitochondrial function and energy production in heart cells. Mice lacking PGC-1alpha showed signs of heart failure, including reduced contractility. The study confirmed that PGC-1alpha regulates key metabolic pathways in the heart and could be a potential target for heart failure treatment. These findings reinforce the idea that PGC-1alpha is important for cardiac function and may offer new therapeutic options.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Utility of Post-Procedural HFA-PEFF Reassessment for Long-Term Heart Failure Risk Stratification After Atrial Fibrillation Ablation.

Journal of arrhythmia·2026
Same author

Incidence and Predictors of New-Onset Heart Failure After Catheter Ablation for Atrial Fibrillation in Patients With a Preserved Ejection Fraction.

Circulation reports·2026
Same author

Characterisation and Enhanced Residual Risk Stratification of Long-Term Post-Discharge Ischaemic Events After Atrial Fibrillation Catheter Ablation.

TH open : companion journal to thrombosis and haemostasis·2026
Same author

Dantrolene attenuates steatohepatitis and liver fibrosis by suppressing Ca<sup>2+</sup> dysregulation.

Biochemical and biophysical research communications·2026
Same author

Remote blunt chest trauma as a cause of right ventricular deformity: multimodality evaluation.

Journal of echocardiography·2026
Same author

Bronchial-to-right coronary extracardiac collateral adjacent to the left pulmonary vein antrum: implications for pulsed field ablation.

European heart journal. Case reports·2026

Area of Science:

  • Cardiovascular physiology
  • Metabolic regulation
  • Heart failure therapeutics

Background:

Heart function relies on precise metabolic control. Prior research has shown that mitochondrial activity and energy production are vital for cardiac performance. However, the exact mechanisms by which the heart adapts metabolically remain unclear. No prior work had resolved how PGC-1alpha influences heart metabolism. This gap motivated the current investigation into PGC-1alpha's role in cardiac function. Established knowledge includes the importance of PGC-1alpha in muscle and liver metabolism. Yet, its specific function in heart tissue was uncertain. This uncertainty drove the need for direct experimental validation. The current study builds on prior findings to clarify PGC-1alpha's role in the heart.

Purpose Of The Study:

The study aimed to determine whether PGC-1alpha regulates cardiac metabolism and whether it could serve as a therapeutic target in heart failure. The researchers sought to test long-postulated functions of PGC-1alpha in heart tissue. They wanted to confirm or refute hypotheses about its role in energy production and mitochondrial function. The motivation stemmed from the lack of direct evidence linking PGC-1alpha to heart failure. The study focused on whether PGC-1alpha could be manipulated to improve cardiac function. Researchers also aimed to assess the consequences of PGC-1alpha deficiency in the heart. The goal was to clarify whether PGC-1alpha is a viable target for future therapies. This work addresses a key unresolved question in metabolic cardiology.

Keywords:
PGC-1alpha functioncardiac energy productionheart failure treatmentmetabolic regulation

Frequently Asked Questions

PGC-1alpha regulates mitochondrial activity and energy production in heart cells, as shown in mice with PGC-1alpha deficiency.

They used genetically modified mice to study PGC-1alpha's effects on metabolism and contractility.

Mitochondrial energy production is essential for maintaining heart contractility and preventing failure.

PGC-1alpha influences gene expression patterns related to metabolic pathways in heart tissue.

Related Experiment Videos

Main Methods:

The researchers used genetically modified mice to study PGC-1alpha's effects on heart function. They created models with PGC-1alpha deficiency in cardiac tissue. These models allowed them to observe metabolic changes in the absence of PGC-1alpha. The team measured mitochondrial activity and energy production in heart cells. They also analyzed gene expression patterns related to metabolism. Experimental tools included molecular biology techniques and functional assays. The approach combined genetic manipulation with physiological testing. This method enabled direct assessment of PGC-1alpha's role in cardiac metabolism.

Main Results:

The strongest finding was that PGC-1alpha is essential for maintaining cardiac metabolism. Mice lacking PGC-1alpha showed impaired mitochondrial function and reduced energy production. These mice exhibited signs of heart failure, including reduced contractility. Gene expression analysis revealed decreased activity of metabolic genes. The study confirmed that PGC-1alpha regulates key metabolic pathways in the heart. It also disproved some earlier hypotheses about PGC-1alpha's role in cardiac adaptation. The results support the idea that PGC-1alpha is a novel therapeutic target. These findings align with the authors' hypothesis about PGC-1alpha's importance in heart function.

Conclusions:

The authors conclude that PGC-1alpha plays a central role in cardiac metabolism. Their findings confirm long-postulated functions of PGC-1alpha in heart tissue. The study shows that PGC-1alpha is crucial for maintaining mitochondrial activity. The results suggest that PGC-1alpha could be a viable target for heart failure treatment. The authors propose that restoring PGC-1alpha may improve cardiac function in patients. They emphasize the need for further research into PGC-1alpha-based therapies. The study provides a foundation for future work on metabolic heart disease. The authors state that their findings reinforce the logic of targeting PGC-1alpha in heart failure.

The study measured mitochondrial activity, energy production, and contractility in genetically modified mice.

The authors suggest that restoring PGC-1alpha could be a novel treatment for heart failure.